Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States. The company offers WAKIX (pitolisant), a m...
Q1 2026
May 7, 2026
FY 2025
Feb 24, 2026
Q4 2025
Q3 2025
Nov 4, 2025
Q2 2025
Aug 5, 2025
